EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

Cytisinicline to Speed Smoking Cessation in the United States

Jonathan Foulds, Sophia I Allen, Jessica Yingst

JAMA · 2023

DOI: 10.1001/jama.2023.5939 ↗

Kurz gefasst

Editorial in der Zeitschrift JAMA, 2023. Verfasst von Jonathan Foulds und 2 weiteren Autor:innen. Beteiligte Einrichtung: Penn State Center for Research on Tobacco and Health, Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania. Hauptthemen laut MEDLINE: Cigarette Smoking, Quinolizidine Alkaloids, Smoking Cessation, Smoking Cessation Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cigarette SmokingQuinolizidine AlkaloidsSmoking CessationSmoking Cessation AgentsTobacco Use DisorderAlkaloidsAzocinesQuinolizinesTime FactorsUnited States

Substanzen

AlkaloidsAzocinescytisineQuinolizidine AlkaloidsQuinolizinesSmoking Cessation Agents

Autor:innen und Institutionen

  • Penn State Center for Research on Tobacco and Health, Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.

Förderung

  • NIDA NIH HHS

Zitieren

APA

Foulds, J., Allen, S. I., & Yingst, J. (2023). Cytisinicline to Speed Smoking Cessation in the United States. JAMA. https://doi.org/10.1001/jama.2023.5939

Vancouver

Foulds J, Allen SI, Yingst J. Cytisinicline to Speed Smoking Cessation in the United States. JAMA. 2023. doi:10.1001/jama.2023.5939

BibTeX
@article{Foulds2023,
  author = {Foulds, Jonathan and Allen, Sophia I and Yingst, Jessica},
  title = {Cytisinicline to Speed Smoking Cessation in the United States},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.5939}
}
Kostenlos starten →